Prestige Consumer Healthcare (PBH) FY2015 results: revenue $715 million, up 19.6% on the year
Prestige Consumer Healthcare Inc. (PBH) reported revenue of $715 million for fiscal 2015, the year ended 31 March 2015, up 19.6% on the year before. Net income was $78 million, up 7.8%, and diluted earnings per share $1.49. The figures are the company's own, from the 10-K it filed with the SEC on 14 May 2015.
Revenue
$715 million
+19.6% on the year
FY2010FY2015
Operating margin
29.0%
31.6% a year earlier
FY2010FY2015
Net income
$78 million
+7.8% on the year
FY2010FY2015
Diluted EPS
$1.49
+7.2% on the year
FY2010FY2015
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Revenue
715
597
620
+19.6%
Gross profit
406
336
344
+21.1%
Gross margin
56.8%
56.2%
55.4%
Operating income
208
189
192
+10.0%
Operating margin
29.0%
31.6%
30.9%
Interest expense
81.3
68.6
84.4
+18.5%
Pre-tax income
127
102
106
+25.3%
Income tax
49.2
29.1
40.5
+68.9%
Effective tax rate
38.6%
28.6%
38.2%
Net income
78.3
72.6
65.5
+7.8%
Net margin
11.0%
12.2%
10.6%
Diluted EPS
$1.49
$1.39
$1.27
+7.2%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Operating cash flow
156
112
138
+40.0%
Capital expenditure
6.1
2.8
10.3
+120.7%
Free cash flow
150
109
127
+38.0%
Free cash flow margin
21.0%
18.2%
20.5%
Cash from investing
-805
-58.0
11.2
Cash from financing
643
-41.2
-152
Depreciation and amortisation
17.7
13.5
13.2
+31.5%
Share-based compensation
6.9
5.1
3.8
+34.4%
Dividends paid
0.0
0.0
0.0
Diluted shares, weighted
53m
52m
51m
+0.6%
Balance sheet
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Shareholders' equity
628
563
478
+11.4%
Debt
1,561
934
971
+67.1%
Other liabilities
453
298
291
+52.1%
Total liabilities and equity
2,642
1,796
1,740
+47.1%
Fixed assets
13.7
9.6
9.9
+43.2%
Goodwill
291
191
168
+52.2%
Intangible assets
2,135
1,395
1,373
+53.0%
Cash and equivalents
21.3
28.3
15.7
-24.8%
Receivables
87.9
65.0
73.1
+35.1%
Inventory
74.0
65.6
60.2
+12.8%
Other assets
19.7
41.4
40.2
-52.4%
Total assets
2,642
1,796
1,740
+47.1%
10-K for the year ended 31 March 2015, filed 14 May 2015: the filing.